本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corvus Pharmaceuticals, Inc.

10.05
-0.4700-4.47%
盘后:10.050.00000.00%16:15 EDT
成交量:71.96万
成交额:728.03万
市值:8.42亿
市盈率:-16.07
高:10.52
开:10.43
低:10.02
收:10.52
52周最高:26.95
52周最低:6.39
股本:8,376.77万
流通股本:7,412.01万
量比:0.57
换手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):-0.6252
每股收益(LYR):-0.5320
净资产收益率:-35.43%
总资产收益率:-21.66%
市净率:3.74
市盈率(LYR):-18.89

数据加载中...

2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/01

重要事件披露

Form 8-K - Current report
2024/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

重要事件披露

Form 8-K - Current report
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/08

重要事件披露

Form 8-K - Current report